Christoph_Oing

Med Onc at UKE Hamburg. @myESMO #ESMOYOC member, former @myESMO fellow. GU cancer specialist. Focus early phase trials 🎯💊 / translational research 🧬🧫🔬.

[Christoph_Oing @OingC1]

New research from my MSNZ HaTriCs4 lab group @UKEHamburg. PCa patient-derived models to assess sensitivity to PARPi/CDDP.

[Molecular Oncology @MolOncology]

👉In case you missed this

Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease

🔗https://t.co/vL400O6hQa

#HomologousRecombinationRepair
#Olaparib #PARPi #PCSM

[Christian D. Fankhauser @CDFankhauser]

#UROonco23 testis cancer session @OingC1 @Alex_Papachris @Hielke_Martijn @MaartenAlbersen discussing the role of surgery chemotherapy and radiotherapy in stage 2 @YAUpenile_tesCa

[Alastair Greystoke @AlastairGreyst2]

Job for a clinical fellow helping with oncology trials @Newcastle_ECMC @Nuth_OHR.

All previous incumbents have enjoyed themselves, built CVs and practiced baking amongst other skills
https://t.co/JtxA4mseJV

[Liz Connolly @DrLizConnolly]

Come join the #ESMOYOC!
Applications close 21 Nov 2022 👇

[Christoph_Oing @OingC1]

#ESMO22 Come and join the ESMO YO Brunch session to discuss with @aftimosp about Molecular Tumor Boards at 11am in 7.3 Rennes!

[Christoph_Oing @OingC1]

Come and join us for the first ESMO Resilience Task Force Workshop at #ESMO22 at 10am this morning in La Serre - Hall 6.2

[Kevin Punie @kevinpunie]

#ESMO22 #ESMOYOC
@myESMO Resilience Task Force kindly invites you to attend the Special Session tomorrow at 10 AM in La Serre - Hall 6 - level 2
👉Sharing strategies and coaching-style exercise to 🚀your own wellbeing and resilience for oncology professionals
@OncoAlert #ESMORTF

[Prof Ananya💙 @achoud72.bsky.social @achoud72]

Great opportunity to join us and study #radiosensitivity & #prostatecancer thanks to @ProstateUK Work hard & play hard - it's translational & clinically relevant 🥳 @MCRCnews @UoM_DCS @TheBACR @AssocRadRes @ESTRO_RT @davidcwedge
https://t.co/vjH34N6IWY

[ESMO - Eur. Oncology @myESMO]

Soft Tissue #Sarcomas webinar airing in just a few hours. Register now and get your certificate of attendance and 1 ESMO-MORA point
⏰ 29/3, 18:30 CEST
🔗 https://t.co/fOzMFafkVj

@AliceIndini @SilviaStacchia @pawel_sobczuk @jeanyvesblay #scmsm

[ESMO - Eur. Oncology @myESMO]

#ESMOTAT22 Virtual Lounge exploring 'How to become an expert in early phase trials & drug discovery research' w/ Timothy Yap, @rillepihlak & @OingC1 - your chance to discuss & exchange w/ peers & experts. Open to all event participants.
⏰ 7 Mar, 19:30 CET
https://t.co/PvKYNXPm5G

[Pawel Sobczuk @pawel_sobczuk]

#ESMOSarcoma22 starting tomorrow!
🚨Don't miss our sessions for young oncologists!
🔸Mentorship session (31/1, 17:30) with @JTrentMDPhD @DrCeSarcoma
🔸Vesalius Talk: How to improve tx outcomes for #sarcoma pts? (1/2, 18:15) with @DrMehdiBrahmi @BrotoJavier
@myESMO @OncoAlert

[Tom Powles @tompowles1]

Elena Castro #emuc21 describes the DDR biomarker for PARPi in prostate cancer. BRCA1/2 are the most relevant DNA alterations. ctDNA is an attractive alternative to archived tissue. DDR alterations occur early. PARPi has an important role in prostate cancer @ChrisSweens1

[Teresa Amaral, MD, PhD @TeresaSAmaral]

Thank you for 5⭐'s feedback @aaronctan
For those considering applying to the #ESMOYOC virtual #mentorship program, there is still time 👋. All you need to know is at @myESMO website on the YOC corner!
#Women4Oncology #careerdevelopment

[Jon Lim, MRCP PhD @DrJonLim]

💥 So excited about the upcoming #ESMOYOC sessions at #ESMOasiaweek21:

🗓 Sun 21/11 - Adapting data from practice-changing studies into daily practice in Asia: @LoiSher @herbloong

🗓 Mon 22/11 - Running clinical trials in Asia: @TonyMok9

Hope to see you there. Don’t miss it!

[Maria Kfoury @kfoury_maria]

The #ESMOYOC virtual mentorship programme is open for applications. It's a great opportunity to be matched with @myESMO Leader for a 1:1 mentorship 12-months programme. Applications are open until Nov 21st.
👇https://t.co/14Hwa8u0Eu

[Rille @rillepihlak]

All medical students and trainees interested in oncology- join us later today to see how #ESMO can help you in your career!
@myESMO @TeresaSAmaral @pawel_sobczuk

[ESMO - Eur. Oncology @myESMO]

New #ESMOYOC Virtual #Mentorship session for #medicalstudents & new physicians on ESMO activities for medical students, poster prep & presentation, & virtual poster walk 🙌 11 Nov 17:00 CET
👉 Join us (free) https://t.co/yfohs4zs1c
@TeresaSAmaral @rillepihlak @pawel_sobczuk

[Teresa Amaral, MD, PhD @TeresaSAmaral]

Don't forget to apply to this amazing program! 😊 #virtualmentorship #careerdevelopment
@myESMO #esmoyoc
@DrJonLim @matteolambe @kevinpunie @pawel_sobczuk @EMariamidze @rillepihlak @kfoury_maria @OingC1 @clacardone @franclongo @KFumasoli

[Christian D. Fankhauser @CDFankhauser]

among many others incredible speakers
@JimCatto @AlbigesL @GGiannarini @albertobrigant1 @F_Montorsi @OingC1 @Silke_Gillessen @mdesantis234 @piet_ost @MRoupret @stefanofanti4 @declangmurphy @ProfPadhani @philcornford @PBlanchardMD @joniau @veerukasi @amerseburger @OudardStephane

[Rille @rillepihlak]

Join me and @iamdonnagraham discussing the impact of Covid19 on early phase trials tomorrow @myESMO #MAP2021 conference!
Let's discuss the lessons learned and where can we go next? 🤓👩‍🏫
PS! #MAP2021 is free for all ESMO members😉

[ESMO - Eur. Oncology @myESMO]

#ESMO21: Results from the SAKK 01/10 trial demonstrate favourable PFS and low toxicity with single-dose carboplatin and involved-node #radiotherapy.
👉https://t.co/jmDwfJq4RS
#tscsm #seminoma @robert_huddart